Compare Abbott Laboratories (ABT) vs ProShares Bitcoin ETF (BITO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs ProShares Bitcoin ETF — how do they compare? Abbott Laboratories trades at $95.54 (market cap $166.94B), while ProShares Bitcoin ETF trades at $8.38. The key difference: Abbott Laboratories pays a 2.63% dividend while ProShares Bitcoin ETF pays none, and Abbott Laboratories is trading nearer its 52-week high, ProShares Bitcoin ETF nearer its low. Which is the better fit depends on your goals.
| ABT | BITO | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | Crypto-linked |
52-Week High | $136.62 | $23.05 |
52-Week Low | $82.57 | $7.98 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
BITO trades at $8.64, up 3.6% over 24 hours amid a mixed technical picture with a bullish overall signal but bearish moving averages. Recent dividend distributions of $0.01-$0.02 per share provide modest income, though financial ratios like P/E and P/S are unavailable. News sentiment reflects caution as the fund faces scrutiny over performance gaps versus Bitcoin and fee structures.
Outlook remains clouded by volatile crypto markets and investor skepticism; risks include fee drag and regulatory uncertainty. Analysts highlight distribution cuts and correlation shifts, suggesting limited near-term catalysts. Investors should weigh income against potential capital erosion in a challenging environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About ProShares Bitcoin ETF
BITO offers exposure to Bitcoin returns primarily through Bitcoin futures contracts. It provides a regulated way for investors to trade Bitcoin performance within a traditional brokerage account without direct ownership.
Read more on BITO →
